FDA recall, , Moderate risk
American National Red Cross Cryoprecipitated AHF
American National Red Cross Cryoprecipitated AHF failed to meet minimum specifications for fibrinogen levels.
Recall ended May 19, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The American National Red Cross recalled Cryoprecipitated AHF and Pooled Cryoprecipitated AHF products because they failed to meet the minimum specifications for fibrinogen levels. The recall began March 8, 2024, and was added to the FDA's Enforcement Report on May 19, 2026. The products were distributed in Alabama, Georgia, Illinois, Massachusetts, Maryland, Michigan, New Jersey, New York, Ohio, Pennsylvania, Texas and the District of Columbia.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
2 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Cryoprecipitated AHF
Reason: Cryoprecipitated AHF, that failed to meet the minimum specifications for fibrinogen levels, were distributed.
Pooled Cryoprecipitated AHF
Reason: Pooled Cryoprecipitated AHF, that failed to meet the minimum specifications for fibrinogen levels, were distributed.
Recall details
- Company began the recall
- Sold in
- 11 states and DC
- Company
- American National Red Cross (the)
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98684
- Recall numbers
- B-0061-2026 to B-0062-2026
All recalls from American National Red Cross (the)
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
